default author photo

William D. Figg

Government of the United States of America - National Cancer Institute

9609 Medical Center Drive

Rockville, MD 20850

United States

SCHOLARLY PAPERS

2

DOWNLOADS

153

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Final Results from a Phase 1 Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or with Ipilimumab for Advanced/Metastatic Genitourinary Tumours

Number of pages: 73 Posted: 26 Jun 2023
National Institutes of Health (NIH) - Bladder Cancer Section, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Biostatistics and Data Management Section, National Institutes of Health - Developmental Therapeutics Branch, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Laboratory of Translational Genomics, Government of the United States of America - Center for Cancer Research, National Institutes of Health (NIH) - Laboratory of Pathology, Government of the United States of America - Laboratory of Pathology, Government of the United States of America - Laboratory of Pathology, Government of the United States of America - Clinical Center, Government of the United States of America - Clinical Center, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Urologic Oncology Branch, Government of the United States of America - Urologic Oncology Branch, Government of the United States of America - Urologic Oncology Branch, Government of the United States of America - Urologic Oncology Branch, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, Government of the United States of America - Division of Cancer Prevention, National Institutes of Health (NIH) - Clinical Immunotherapy Section, Rutgers University, New Brunswick - Rutgers Cancer Institute of New Jersey, City of Hope - Comprehensive Cancer Center, University of Southern California, Columbia University - Herbert Irving Comprehensive Cancer Center, University of California, Davis - Comprehensive Cancer Center, Government of the United States of America - Center for Cancer Research and Ohio State University (OSU) - Department of Internal Medicine
Downloads 114 (621,896)

Abstract:

Loading...

Urothelial Carcinoma, Rare Genitourinary Tumours, Immunotherapy, Immune Correlates Of Antitumor Response, Renal Medullary Carcinoma, Bladder Squamous Cell Carcinoma, Squamous Cell Carcinoma Of The Penis, Bladder Adenocarcinoma, Urachal Carcinoma, Cabozantinib

2.

Determination of the Endogenous Oatp1b Biomarkers Glycochenodeoxycholate-3-Sulfate and Chenodeoxycholate 24-Glucuronide in Human and Mouse Plasma

Number of pages: 28 Posted: 27 Jun 2022
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Government of the United States of America - National Cancer Institute, affiliation not provided to SSRN, Ohio State University (OSU) and affiliation not provided to SSRN
Downloads 39 (1,196,171)

Abstract:

Loading...

Endogenous biomarkers, Drug-drug interactions, UHPLC-MS/MS, OATP1B transport, bile acids